Basal and postprandial serum levels of gastrin in normotensive and hypertensive adults

Clinical and Experimental Hypertension

Volumn 35, Issue 1, 2013, Pages 74-78

  Jiang, Xiaoliang ^a   Wang, Wenjie ^a   Ning, Bin ^b   Liu, Xing ^a   Gong, Jian ^b   Gan, Fusheng ^b   Gao, Xuezhong ^b   Zhang, Lianfeng ^a   Jose, Pedro A ^c   Qin, Chuan ^a   Yang, Zhiwei ^a  

^a BEIJING HOSPITAL   (China)

^b Fuyang People's Hospital   (China)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Aldosterone; Angiotensin II; Gastrin; Hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; GASTRIN; RENIN; SODIUM; WATER;

ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GASTRIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTPRANDIAL STATE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE; SODIUM METABOLISM; WATER METABOLISM;

ADULT; ALDOSTERONE; ANGIOTENSIN II; BLOOD PRESSURE; CASE-CONTROL STUDIES; FASTING; FEMALE; GASTRINS; HUMANS; HYPERTENSION; MALE; POSTPRANDIAL PERIOD; RENIN; RENIN-ANGIOTENSIN SYSTEM; WATER-ELECTROLYTE BALANCE;

EID: 84871790804     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.690474     Document Type: Article

References (38)

1. Michell AR, Debnam ES, Unwin RJ. Regulation of renal function by the gastrointestinal tract: potential role of gut-derived peptides and hormones. Annu Rev Physiol 2008; 70:379-403.
2. Wank SA. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family. Am J Physiol 1998; 274:G607-G613.
3. Pisegna JR, Tarasova NI, Kopp JA, et al. Postprandial changes in renal function are mediated by elevated serum gastrin acting at cholecystokinin type B receptors (CCKBR) in the kidney. Gastroenterology 1996; 110:1106A.
4. Koh TJ. Extragastric effects of gastrin gene knock-out mice. Pharmacol Toxicol 2002; 91:368-374.
5. Jose PA, Eisner GM, Felder RA. Role of dopamine in the pathogenesis of hypertension. Clin Exp Pharmacol Physiol Suppl 1999; 26:S10-S13.
6. von Schrenck T, Ahrens M, de Weerth A, et al. CCKB/gastrin receptors mediate changes in sodium and potassium absorption in the isolated perfused rat kidney. Kidney Int 2000; 58:995-1003.
7. Levy D, EhretGB, Rice K, et al.Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41: 677-687.
8. Wang Y, O'Connell JR, McArdle PF, et al. Fromthe cover: wholegenome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106: 226-231.
9. Cho YS, Go MJ, Kim YJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009; 41:527-534.
10. Van Orshoven NP, Jansen PA, Oudejans I, Schoon Y, Oey PL. Postprandial hypotension in clinical geriatric patients and healthy elderly: prevalence related to patient selection and diagnostic criteria. J Aging Res 2010; 2010:243752.
11. Hlebowicz J, Lindstedt S, Bjorgell O, Dencker M. The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure. Cardiovasc Ultrasound 2011; 9:43.
12. Calam J, Gordon D, Peart WS, Taylor SA, Unwin RJ. Renal effects of gastrin C-terminal tetrapeptide (as pentagastrin) and cholecystokinin octapeptide in conscious rabbit and man. Br J Pharmacol 1987; 91:307-314.
13. Phillips WT. Opposing glucose set points hypothesis of essential hypertension. Med Hypotheses 2006; 66:22-37.
14. Khan S, Briggs H, Abelson JL. Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses. Psychiatry Res 2008; 158:141-146.
15. Bie P. Blood volume, blood pressure and total body sodium: internal signalling and output control. Acta Physiol (Oxf) 2009; 195:187-196.
16. Titze J, Machnik A. Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens 2010; 19:385-392.
17. Huang BS, Amin MS, Leenen FH. The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol 2006; 21:295-304.
18. Cowley AW Jr. Renal medullary oxidative stress, pressurenatriuresis, and hypertension. Hypertension 2008; 52:777-786.
19. Granger JP, Alexander BT, Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep 2002; 4:152-159.
20. Muntzel M, Drüeke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992; 5(4 Pt 1): 1S-42S.
21. De Weerth J, Schade S, Wolf P. Gastrin/cholecystokinin type B receptors in the kidney: molecular, pharmacological, functional characterization, and localization. Eur J Clin Invest 1998; 28: 592-601.
22. Ewart HS, Klip A. Hormonal regulation of the Na-K- ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 1995; 269:C295-C311.
23. Kopin AS, Lee YM, McBride EW, et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992; 89:3605-3609.
24. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 1992; 89:3125-3129.
25. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008; 294:H551-H569.
26. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol 2006; 2:637-650.
27. Soares-da-Silva P, Pestana M, Ferreira A, Damasceno A, Polónia J, Cerqueira-Gomes M. Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure. Clin Exp Hypertens 2000; 22:251-256.
28. Banday AA, Lokhandwala MF. Dopamine receptors and hypertension. Curr Hypertens Rep 2008; 10:268-275.
29. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000; 62:621-647.
30. Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TV. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem 2007; 7:1154-1165.
31. Melis M, Krenning EP, Bernard BF, de Visser M, Rolleman E, de Jong M. Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences. Nucl Med Biol 2007; 34:633-641.
32. MacGregor GA, Fenton S, Alaghband-Zadeh J, Markandu ND, Roulston JE, de Wardener HE. An increase in a circulating inhibitor of Na,K-dependent ATPase: a possible link between salt intake and the development of essential hypertension. Clin Sci (Lond) 1981; 61:17s-20s.
33. Clough DL, Pamnani MB, Haddy FJ. Decreased myocardial Na-K-ATPase activity in one-kidney, one-clip hypertensive rats. Am J Physiol 1983; 245:H244-H251.
34. Hall JE. Historical perspective of the renin-angiotensin system. Mol Biotechnol 2003; 1:27-39.
35. Chow L, Zakrzewska K, De Gasparo M, Cumin F, Levens N. Gastric acid secretion after blockade of angiotensin AT1 receptors in the Na-depleted rat. Eur J Pharmacol 1995; 294:309-317.
36. Wank SA. Cholecystokinin receptors. Am J Physiol 1995; 269: G628-G646.
37. Molinari C, Battaglia A, Grossini E, et al. Activation of the reninangiotensin system contributes to the peripheral vasoconstriction reflexly caused by stomach distension in anaesthetized pigs. Exp Physiol 2003; 88:359-367.
38. Degli Uberti EC, Trasforini GC, Rotola CA, Margutti AR, Pansini R. Pentagastrin does not affect the renin-angiotensinaldosterone system in man. Panminerva Med 1981; 23: 239-241.